Mebeverin Aristo

Mebeverine Hydrochloride, the active ingredient in Mebeverin Aristo, is an antispasmodic presented as an oral dosage form for oral use. It relaxes smooth muscle in the gastrointestinal tract and is employed to alleviate symptoms of irritable bowel syndrome and other functional gastrointestinal disorders in adult patients.

GNH USA supplies Mebeverin Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution. Clients benefit from consistent product availability and comprehensive regulatory support.

Mebeverine Hydrochloride is used to manage disorders of gastrointestinal smooth muscle activity.

Irritable bowel syndrome: reduces abdominal cramping and pain associated with bowel habit irregularities. Functional gastrointestinal disorders: alleviates spasmodic discomfort in conditions such as functional dyspepsia. Abdominal pain due to intestinal spasm: relaxes intestinal smooth muscle to lessen pain episodes.

Mebeverine Hydrochloride may be associated with several adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset. - Headache: transient headache. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Cardiac arrhythmia: irregular heartbeat. - Severe hypotension: marked drop in blood pressure.

When prescribing Mebeverine Hydrochloride, clinicians should consider several precautionary measures to ensure safe use.

- Assess medical history: verify absence of hypersensitivity to mebeverine or excipients. - Monitor cardiovascular status: caution in patients with known arrhythmias or hypotension. - Evaluate hepatic function: use with care in patients with liver impairment. - Consider pregnancy status: avoid unless benefit outweighs risk. - Review concomitant medications: check for potential interactions affecting calcium channels. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Mebeverine Hydrochloride can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - CYP3A4 inhibitors: may increase mebeverine plasma levels, raising risk of adverse effects. - Strong anticholinergic agents: additive antispasmodic effect may cause severe constipation.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: potential additive smooth‑muscle relaxation. - Antidepressants (SSRIs): monitor for enhanced gastrointestinal effects. - Antihistamines: may increase sedation or dizziness.